Aortic Stenosis, Severe
26
7
11
3
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
3.8%
1 terminated out of 26 trials
75.0%
-11.5% vs benchmark
12%
3 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (26)
Same-Day Versus Standard Hospital Discharge After TAVI (HOME-TAVI)
MRI in Randomised Cohorts of Asymptomatic AS
Selection of Transcatheter Heart vaLve With Intermediate Sizing in Patients With Severe Aortic Stenosis Treated With Transcatheter Aortic Valve Replacement
ALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve
Valvosoft Outcomes Registry for Real-World Evidence
TRanscatheter Aortic-Valve Implantation With or Without On-site Cardiac Surgery: the TRACS Trial
A Study to Obtain Imaging Data in 40 Patients Having Transcatheter Aortic Valve Implantation (TAVI)
CT-evaluation of Coronary Ostia Height After Surgical Aortic Valve Replacement.
China S3 PMS: SAPIEN 3 China Post Market Registry Study
Predictive Value of Pre-TAVI Infrahissian Conduction Time in the Occurrence of Complete Atrioventricular Block
The CardioFit Trial: Exercise Training Before Aortic Valve Surgery
Influence of Lung Ultrasonography on the Prognosis and Postoperative Outcomes in Cardiac Surgical Patients
Timing And Typology of ConducTIon disturbanCes During TAVI
EARLY TAVR: Evaluation of TAVR Compared to Surveillance for Patients With Asymptomatic Severe Aortic Stenosis
PARTNER 3 Trial - Aortic Valve-in-Valve
Effects of Levosimendan on Cardiac Function After TAVR in Patients With Heart Failure
All Women Comparing Self-expanding ALLEGRA Valve to Any Other Balloon-expandable Valve
Exercise CMR in (p)LF-LG AS
Analysis of Calcium Score of Severe Aortic Stenosis in Patients With and Without Cardiac Amyloidosis (CAUSATIVE Study)
Outcome Prediction in Patients With Aortic Stenosis After TAVI